GLENDALE, Calif. and WALTHAM, Mass., May 14, 2013 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), a physician-driven integrated health care delivery company and Fresenius Medical Care (NYSE: FMS), North America's largest provider of kidney care services, announced today that ApolloMed's subsidiary, ApolloMed ACO (Accountable Care Organization), is teaming with Fresenius Medical Care to provide integrated health care management for its patients with end stage renal disease (ESRD).
Health care for patients with ESRD is often poorly coordinated and expensive because of these patients' multiple comorbid conditions. ApolloMed ACO is partnering with Fresenius Medical Care to provide the highly specialized quality care these patients require.
As part of the agreement, ApolloMed ACO and Fresenius Medical Care will share in operations and financial cost savings from the partnership. The multi-year agreement is built on the successful five-year demonstration project that Fresenius Health Partners, a subsidiary of Fresenius Medical Care, conducted with Medicare beneficiaries on dialysis.
"We are excited to be partnering with Fresenius Medical Care to work together on providing best-in-class quality care and management for our ESRD patients," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc. "ApolloMed has been delivering high-quality care at an efficient cost since 2001. Our growing ACO subsidiary is a valuable next step in maturing from a hospitalist business into a physician-driven integrated healthcare delivery company."
"ApolloMed is an outstanding organization which recognizes that an organized and coordinated approach to caring for patients with kidney disease can make a big difference in the quality of their health," said Peter Sauer, President, Fresenius Health Partners. "Our partnership with ApolloMed will allow us to combine our collective expertise to provide the highest quality and cost effective care for these individuals."
About Apollo Medical Holdings, Inc.
Headquartered in Glendale, California and dedicated to putting the 'Patient First,' ApolloMed is a physician-driven integrated healthcare delivery company, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California. ApolloMed is addressing the healthcare needs of the nation's largest population center by leveraging its integrated healthcare delivery platform through its complementary physician groups: ApolloMed Hospitalists and ApolloMed ACO (Accountable Care Organization). This platform combines hospitalist medicine, critical care medicine, patient care coordination, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. ApolloMed strives to improve medical outcomes with high quality, cost efficient care. For more information, please visit www.apollomed.net.
About Fresenius Medical Care North America
Through our leading network of more than 2,100 dialysis facilities in North America and our vascular access centers, laboratory, pharmacy and affiliated hospitals and nephrology practices, Fresenius Medical Care provides renal services to hundreds of thousands of people throughout the United States, Mexico and Canada. We are also the continent's top producer of dialysis equipment, dialyzers and related disposable products and a major supplier of renal pharmaceuticals. For more information about the company, visit www.fmcna.com; for information about patient services, visit www.ultracare-dialysis.com.
Safe Harbor Statement
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended January 31, 2013 and in any of the Company's other subsequent Securities and Exchange Commission filings.
SOURCE Apollo Medical Holdings, Inc.